Css LLC Amylyx Pharmaceuticals, Inc. Transaction History
Css LLC
- $1.04 Billion
- Q4 2024
A detailed history of Css LLC transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Css LLC holds 31,700 shares of AMLX stock, worth $113,486. This represents 0.04% of its overall portfolio holdings.
Number of Shares
31,700Holding current value
$113,486% of portfolio
0.04%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AMLX
# of Institutions
142Shares Held
49.1MCall Options Held
281KPut Options Held
438K-
Perceptive Advisors LLC New York, NY6.77MShares$24.3 Million0.85% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA4.64MShares$16.6 Million2.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$9.64 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$9.56 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC2.43MShares$8.69 Million0.0% of portfolio
About Amylyx Pharmaceuticals, Inc.
- Ticker AMLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,533,200
- Market Cap $210M
- Description
- Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...